Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) (NCT07637734)
COVE-3: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-302; referred to as COVE-3 \[Cantharidin and Occlusion in Verruca Epithelium\]) to evaluate the efficacy and safety of YCANTH (VP-102/TO-208) treatment in subjects with common warts.
Who can join: Review the eligibility criteria below.
Location: DelRicht Research โ Overland Park, Kansas
Age range: 2 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- DelRicht Research โ Overland Park, Kansas
- DelRicht Research โ Baton Rouge, Louisiana
๐ Contact the Study Coordinator
Phone: (484) 453-3295
Email: 17339-COVE3@allucent.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Common Warts
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) โ Saint Augustine, Florida
Explore by condition: All Common Warts clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.